These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18525007)
21. High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction. Cooper JE; Gralla J; Klem P; Chan L; Wiseman AC Transplantation; 2014 Jun; 97(12):1253-9. PubMed ID: 24937199 [TBL] [Abstract][Full Text] [Related]
22. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
23. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172 [TBL] [Abstract][Full Text] [Related]
24. A role for extrarenal cells in the regeneration following acute renal failure. Gupta S; Verfaillie C; Chmielewski D; Kim Y; Rosenberg ME Kidney Int; 2002 Oct; 62(4):1285-90. PubMed ID: 12234298 [TBL] [Abstract][Full Text] [Related]
25. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092 [TBL] [Abstract][Full Text] [Related]